Wednesday, February 10, 2010, 7:04AM AEST - The Australian Stockmarket opens in 2 hours and 56 minutes.
To create a watchlist or portfolio of shares, Register

Adolor Corp. (ADLR)

6:46AM AEST: 1.46 USD  Up 0.01 (0.69%)  
 MORE ON ADLR 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Adolor Corporation (NGM:ADLR) Delayed quote dataEdit
Last Trade:1.46 USD
Trade Time: 6:46AM AEST
Change:Up 0.01 (0.69%)
Prev Close:1.45
Open:1.51
Bid:1.46 x 500
Ask:1.47 x 2100
1y Target Est:2.90
Day's Range:1.45 - 1.51
52wk Range:1.33 - 2.53
Volume:32,465
Avg Vol (3m):267,952
Market Cap:67.65M
P/E (ttm):N/A
EPS (ttm):-1.21
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add ADLR to Portfolio   Download Data

 HEADLINES 
Adolor Corporation Announces Management Appointments
Business Wire (Fri, Jan 15)
ADOLOR CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Officers
EDGAR Online (Tue, Dec 22)
Adolor Corporation Initiates Clinical Testing in Opioid Bowel Dysfunction Program
Business Wire (Fri, Nov 13)
ADOLOR CORP Financials
EDGAR Online Financials (Thu, Nov 5)
ADOLOR CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Sat, Oct 31)
Adolor Corporation Earnings Call scheduled for 8:45 am ET today
CCBN (Thu, Oct 29)
ADOLOR CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Oct 29)
This Partnership Will Go No Further
at Motley Fool (Fri, Oct 16)
ADOLOR CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Sep 24)
Pharmacoeconomic Analysis of Reported Use of ENTEREG(R) (alvimopan) Published in American Journal of Health-System Pharmacy
Marketwire (Fri, Aug 21)
More Headlines for ADLR...

 ANALYST 
EPS Est (next year) (Dec-09) :-1.08
EPS Est (in 2 years) (Dec-10) :-0.53
Avg Rec (current)*:3.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Adolor Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of prescription pain management products.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices